The results of the pathway protein assay showed that the protein expressions of TLR4 and JNK were overtly decreased in the treatment group and markedly increased in the model group, suggesting that the treatment with erdosteine promotes the recovery of otitis media. Here, MAPK8 is linked to otitis media.